Organogenesis Holdings Inc - Ordinary Shares - Class A
ORGO
Get informed when a big investor buys or sells
+ FollowMarket Cap$308.82M
Close$
$0.23
90% downside
Current Fair Value
90% downsideOvervalued by 90% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $308.82 Million |
|---|---|
| Enterprise Value | $288.30 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.16 |
| Beta | 1.33 |
| Outstanding Shares | 127,797,013 |
Return
| Return on Equity | 5.13% |
|---|---|
| Return on Assets | 2.41% |
| Return on Invested Capital | 0.48% |
Valuation & Multiples
| P/E Ratio | -16.42 |
|---|---|
| PEG | -10.25 |
| Price to Sales | 0.59 |
| Price to Book Ratio | 1.17 |
| Enterprise Value to Revenue | 0.56 |
| Enterprise Value to EBIT | 136.7 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.25 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.29
Average shareholder expectationRevenue Estimate
$43.26 M
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.35
Average shareholder expectationRevenue Estimate
$54.27 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 88.43% |
|---|---|
| Total Calls | 36,900▲ 204.96% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 48.99%▼ 5.78% |
|---|---|
| Total Invested | $147.61M▼ 58.97% |
| Investors Holding | 121▼ 27.00% |
ESG Score
No data